Name | Type | Posted | Actions |
|---|---|---|---|
RFQ 75F40126Q00120 final.pdf | Apr 20, 2026 |
FLOWSHEET MODELING AND SIMULATION SOFTWARE LICENSE SUPPORT AND MAINTENANCE
Contact and place of performance
Robert Waite
Silver Spring, MD 20993
USA
The objective is to purchase a new license for gPROMS or equal to flowsheet modeling and simulation platform including model libraries for blending, granulation, milling, feeding, compression, tablet coating, oral absorption, crystallization, and drying.
See Attachement for complete details.
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with part 12. This announcement constitutes the only solicitation. Offers are being requested and a separate written solicitation will not be issued.
The Government is in no way obligated to make an award, nor to pay any costs incurred by the Contractor in preparing and submitting its quote.
The Food and Drug Administration (FDA) Center for Drug Evaluation and Research is seeking to purchase a new license for gPROMS or an equivalent flowsheet modeling and simulation platform. This software must include specialized model libraries for blending, granulation, milling, feeding, compression, tablet coating, oral absorption, crystallization, and drying. This procurement is a combined synopsis/solicitation for commercial products or services under Solicitation Number 75F40126Q00120, and no separate written solicitation will be issued.
This requirement is classified under NAICS 423430, Computer and Computer Peripheral Equipment and Software Merchant Wholesalers, and PSC 7A20, IT and Telecom - Application Development Software (Perpetual License Software). There is no set-aside designated for this action. Performance will take place in Silver Spring, Maryland, and Robert Waite serves as the point of contact.
Responses are due by April 27, 2026. The solicitation was published on April 20, 2026, and includes one attachment titled RFQ 75F40126Q00120 final.pdf. The government maintains the right to not make an award and will not reimburse costs associated with quote preparation.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.